Terns Pharmaceuticals

Terns Pharmaceuticals

Biotechnology Research

Foster City, California 8,424 followers

Taking the Journey Towards Comprehensive Treatment of Serious Disease

About us

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline includes three clinical-stage development programs including an allosteric BCR-ABL inhibitor, a small-molecule GLP-1 receptor agonist, a THR-β agonist and preclinical GIPR modulator programs. For more information, please visit: www.ternspharma.com. Disclaimer: Reposts and posts of contents are for informational purposes only and do not constitute endorsements or promotions of any third-party products, services or organizations (including any statements, views or conducts by such organizations) unless explicitly stated otherwise.

Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
Foster City, California
Type
Privately Held
Founded
2017
Specialties
Pharmaceuticals, Liver Disease, Life Sciences, and BioPharmaceuticals

Locations

  • Primary

    1065 E Hillsdale Blvd

    Suite 100

    Foster City, California 94404, US

    Get directions

Employees at Terns Pharmaceuticals

Updates

Similar pages

Browse jobs

Funding

Terns Pharmaceuticals 6 total rounds

Last Round

Post IPO equity

US$ 150.2M

See more info on crunchbase